Global footprint Lambda Therapeutic Research operates as a global full-service CRO with facilities in India, USA, Canada, UK, Spain, and Poland, presenting a strong multi-region capability to support international trials and market access for clients seeking diverse regulatory environments.

Awarded credibility Recognition as Best Indian CRO and Great Indian Workplace, along with recent Regulatory Excellence and Industry Partner awards, signals proven performance, quality, and organizational stability that can de-risk outsourcing for potential sponsors seeking reliable partners.

End-to-end services A wide service portfolio spanning Phase I to late-phase trials, biosimilars development, pharmacovigilance, medical imaging, data management, and medical writing enables cross-selling opportunities to sponsors requiring integrated clinical research solutions under one partner.

Growth via events Active participation in major industry events (DCAT Week, SCOPE Summit, J.P. Morgan Healthcare Conference, AAD Annual Meeting) creates recurring outreach channels for lead generation, partnership discussions, and showcasing new capabilities to a network of potential clients and collaborators.

Technology stack Adoption of analytics and enterprise tools (SAS, SAP SuccessFactors, Microsoft 365, HubSpot, Piwik PRO) indicates a data-driven operations and customer engagement approach, offering opportunities to position Lambda as a tech-enabled partner for sponsors prioritizing quality, efficiency, and real-time trial oversight.